Selecting and describing control conditions in mobile health randomized controlled trials: a proposed typology

Author:

Goldberg Simon B.ORCID,Sun Shufang,Carlbring PerORCID,Torous JohnORCID

Abstract

AbstractHundreds of randomized controlled trials (RCTs) have tested the efficacy of mobile health (mHealth) tools for a wide range of mental and behavioral health outcomes. These RCTs have used a variety of control condition types which dramatically influence the scientific inferences that can be drawn from a given study. Unfortunately, nomenclature across mHealth RCTs is inconsistent and meta-analyses commonly combine control conditions that differ in potentially important ways. We propose a typology of control condition types in mHealth RCTs. We define 11 control condition types, discuss key dimensions on which they differ, provide a decision tree for selecting and identifying types, and describe the scientific inferences each comparison allows. We propose a five-tier comparison strength gradation along with four simplified categorization schemes. Lastly, we discuss unresolved definitional, ethical, and meta-analytic issues related to the categorization of control conditions in mHealth RCTs.

Funder

U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health

Hope for Depression Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Health Information Management,Health Informatics,Computer Science Applications,Medicine (miscellaneous)

Reference68 articles.

1. WHO. mHealth Use of Appropriate Digital Technologies for Public Health. https://doi.org/10.1371/journal.pmed.1001362 (2018).

2. Goldberg, S. B., Lam, S. U., Simonsson, O., Torous, J. & Sun, S. Mobile phone-based interventions for mental health: a systematic meta-review of 14 meta-analyses of randomized controlled trials. PLoS Digit. Health 1, e0000002 (2022).

3. FDA. FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs. https://www.fda.gov/news-events/press-announcements/fda-clears-mobile-medical-app-help-those-opioid-use-disorder-stay-recovery-programs (2022).

4. FDA. FDA permits marketing of first game-based digital therapeutic to improve attention function in children with ADHD. https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-game-based-digital-therapeutic-improve-attention-function-children-adhd (2022).

5. TBRC. The mobile healthcare market is expected to reach $250. https://www.globenewswire.com/news-release/2022/03/29/2412162/0/en/The-Mobile-Healthcare-Market-Is-Expected-To-Reach-250-Billion-Due-To-The-Rising-Prevalence-Of-Chronic-Diseases-Globally-As-Per-The-Business-Research-Company-s-Mobile-Healthcare-Glo.html (2022).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3